Kevin (Kai-Chung) Shaw Buys 28,000 Shares of Integral Diagnostics (ASX:IDX) Stock

Integral Diagnostics Limited (ASX:IDX) insider Kevin (Kai-Chung) Shaw bought 28,000 shares of the stock in a transaction dated Friday, February 27th. The stock was bought at an average price of A$2.43 per share, with a total value of A$68,040.00.

Integral Diagnostics Price Performance

The company has a debt-to-equity ratio of 124.07, a quick ratio of 1.84 and a current ratio of 0.63. The stock has a market cap of $880.11 million, a P/E ratio of 62.71, a price-to-earnings-growth ratio of 1.39 and a beta of 0.14.

Integral Diagnostics Announces Dividend

The company also recently disclosed a Interim dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Wednesday, April 1st will be issued a dividend of $0.033 per share. The ex-dividend date of this dividend is Tuesday, March 3rd. This represents a dividend yield of 137.0%. Integral Diagnostics’s dividend payout ratio (DPR) is presently -28.08%.

Integral Diagnostics Company Profile

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.